F. Deconno et al., TOLERABILITY OF KETOROLAC ADMINISTERED VIA CONTINUOUS SUBCUTANEOUS INFUSION FOR CANCER PAIN - A PRELIMINARY-REPORT, Journal of pain and symptom management, 9(2), 1994, pp. 119-121
We evaluated the local and systemic tolerability of ketorolac administ
ered through continuous subcutaneous infusion in ten cancer patients.
The patients were monitored daily for the severity and duration of pai
n, and the development of other symptoms. The duration of injection si
te varied from 1 to more than 7 days. No patients complained of local
discomfort or pain. Mild local bleeding at the site of drug injection
was observed in seven cases. No increase in the intensity of symptoms
was observed during the infusion of ketorolac.